drugset / Trial / NCT02842619
Filling Bone Defects/Voids With Autologous BonoFill-II for Maxillofacial Bone Regeneration
NaSingle-groupTreatment
Summary
The purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as a bone filler containing the patient's own (autologous) adipose (fat) tissue-derived cells in reconstructing bone in two clinical indications: 1. Bone augmentation (e.g. sinus augmentation) 2. Bone grafting after removal of cysts from jaws
Timeline
- Start
- 2016-07-23
- Primary completion
- 2024-06-02
- Completion
- 2025-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BonoFill-II | Cell therapy | — | Other |
Indications
No indication recorded.